Bashan Dror
SEC CIK 1781450 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | Pres, CEO, Dir | 188.5K | $293.8K | — | 7 | 2022-02-25 | 2025-12-19 |
Most active insiders at PLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bashan Dror | Pres AND CEO, Dir | $101.4K | — |
| 2 | Bar-Shalev Amos | Dir | — | $314.16 |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | 2025-12-19 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres AND CEO, Dir | P - Purchase | $1.81 | +56.0K | 188.5K | +42% | +$101.4K | |
| DI | 2025-09-04 | 2025-09-03 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres AND CEO, Dir | A - Grant | — | +195.0K | 2.34M | +9% | — |
| I | 2024-04-03 | 2024-04-01 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres AND CEO, Dir | A - Grant | — | +264.0K | 2.15M | +14% | — |
| M | 2023-10-20 | 2023-10-19 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres AND CEO, Dir | P - Purchase | $1.40 | +64.5K | 116.4K | +124% | +$90.5K |
| I | 2023-08-17 | 2023-08-15 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres, CEO, Dir | A - Grant | — | +800.0K | 1.89M | +74% | — |
| 2022-04-13 | 2022-04-11 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres, CEO, Dir | P - Purchase | $1.50 | +68.0K | 68.0K | New | +$102.0K | |
| I | 2022-02-28 | 2022-02-25 | PLX | Protalix BioTherapeutics, Inc. | Bashan Dror | Pres, CEO, Dir | A - Grant | — | +637.5K | 1.09M | +142% | — |
Purchase Sale Sale after option exercise All abbreviations